From: Risk factors for cognitive decline in non-demented elders with amyloid-beta positivity
Variable | No cognitive decline | cognitive decline | Total | p |
---|---|---|---|---|
N | 378 | 272 | 650 | / |
Age, year, mean [SD] | 73.21 [6.67] | 73.93 [6.91] | 73.51 [6.78] | 0.104‡ |
Gender, female/male | 81/194 | 114/158 | 297/353 | 0.101†|
Education, year, mean [SD] | 16.27 [2.75] | 16.08 [2.79] | 16.19 [2.75] | 0.384‡ |
APOE ε4 carrier, yes (%) | 202 (53.44) | 178 (65.44) | 380 (58.46) | 0.004†|
CSF Aβ42, pg/mL, mean [SD] | 765.90 [247.85] | 659.55 [207.98] | 716.35 [236.17] | < 0.001‡ |
CSF p-tau, pg/mL, mean [SD] | 25.85 [13.70] | 34.08 [15.03] | 29.63 [14.90] | < 0.001‡ |
Cognitive composite measures | ||||
Memory function, mean [SD] | 0.49 [0.94] | -0.49 [0.72] | 0.08 [0.98] | < 0.001‡ |
Executive function, mean [SD] | 0.07 [0.85] | -0.59 [0.90] | -0.21 [0.93] | < 0.001‡ |
MMSE, mean [SD] | 27.34 [2.79] | 24.37 [3.47] | 26.10 [3.42] | < 0.001‡ |
MoCA, mean [SD] | 23.62 [3.68] | 20.12 [4.17] | 22.33 [4.22] | < 0.001‡ |
Vital signs | ||||
Body weight, kg, mean [SD] | 77.25 [15.81] | 75.75 [14.54] | 76.63 [15.31] | 0.495‡ |
Body height, cm, mean [SD] | 169.42 [16.90] | 168.89 [10.31] | 169.20 [14.53] | 0.587‡ |
BMI, kg/m2, mean [SD] | 27.51 [9.72] | 26.43 [4.77] | 27.05 [7.99] | 0.128‡ |
Systolic pressure, mmHg, mean [SD] | 135.88 [16.35] | 136.45 [18.27] | 136.12 [17.17] | 0.944‡ |
Diastolic pressure, mmHg, mean [SD] | 75.80 [9.46] | 75.22 [9.32] | 75.56 [9.40] | 0.595‡ |
Pulse pressure, mmHg, mean [SD] | 60.09 [14.74] | 61.23 [16.21] | 60.56 [15.38] | 0.616‡ |
Race |  |  |  | 0.071†|
Asian, yes (%) | 2 (0.53) | 4 (1.47) | 6 (0.92) | Â |
White, yes (%) | 345 (92.00) | 258 (94.85) | 603 (93.19) | Â |
Black, yes (%) | 17 (4.50) | 8 (2.94) | 25 (3.86) | Â |
More than one, yes (%) | 11 (2.52) | 2 (0.73) | 13 (2.01) | Â |
Participant handedness, right (%) | 341 (90.45) | 246 (92.13) | 587 (91.14) | 0.522†|
Parental dementia, yes (%) | 236 (62.59) | 155 (58.05) | 495 (76.86) | 0.228†|
Lifestyle | ||||
Alcohol abuse, yes (%) | 9 (2.38) | 12 (4.41) | 21 (3.26) | 0.140†|
Cigarette abuse, yes (%) | 136 (36.07) | 106 (38.97) | 242 (37.58) | 0.363†|
Drug abuse, yes (%) | 2 (0.53) | 3 (1.10) | 5 (0.78) | 0.400†|
Marital Status, yes (%) |  |  |  | 0.033†|
Married | 270 (71.81) | 220 (80.88) | 490 (75.73) | Â |
divorced | 38 (10.11) | 19 (6.99) | 57 (8.80) | Â |
Widowed | 46 (13.03) | 17 (6.25) | 73 (11.27) | Â |
Never married | 22 (5.85) | 6 (2.21) | 28 (4.32) | Â |
Retired, yes (%) | 300 (80.43) | 224 (86.49) | 524 (83.04) | 0.054†|
Clinical diseases | ||||
Stroke, yes (%) | 2 (0.52) | 7 (2.57) | 9 (1.40) | 0.026†|
Hypertension, yes (%) | 185 (49.07) | 125 (45.96) | 310 (48.14) | 0.551†|
Psychiatric diseases, yes (%) | 126 (33.42) | 95 (34.93) | 221 (34.37) | 0.586†|
Neurologic diseases (other than AD), yes (%) | 103 (27.32) | 79 (29.04) | 182 (28.26) | 0.543†|
Otolaryngology diseases, yes (%) | 239 (63.40) | 179 (65.81) | 418 (64.91) | 0.362†|
Cardiovascular diseases, yes (%) | 248 (65.78) | 172 (63.24) | 420 (65.22) | 0.686†|
Respiratory diseases, yes (%) | 76 (20.16) | 54 (19.85) | 130 (20.19) | 0.997†|
Hepatic diseases, yes (%) | 16 (4.24) | 8 (2.94) | 24 (3.73) | 0.407†|
Dermatologic-Connective Tissue diseases, yes (%) | 129 (34.22) | 88 (32.35) | 217 (33.69) | 0.721†|
Musculoskeletal diseases, yes (%) | 260 (68.97) | 185 (68.01) | 445 (69.10) | 0.970†|
Endocrine-Metabolic diseases, yes (%) | 165 (44.50) | 104 (38.24) | 269 (41.77) | 0.212†|
Gastrointestinal diseases, yes (%) | 189 (50.01) | 113 (41.54) | 302 (46.89) | 0.047†|
Hematopoietic-Lymphatic diseases, yes (%) | 39 (10.34) | 23 (8.45) | 62 (9.63) | 0.457†|
Urinary disease, yes (%) | 159 (42.17) | 117 (43.01) | 276 (42.86) | 0.699†|
Allergies or Drug Sensitivities, yes (%) | 158 (41.90) | 106 (38.97) | 264 (40.37) | 0.556†|
Malignancy diseases, yes (%) | 91 (24.13) | 65 (23.90) | 156 (24.22) | 0.967†|
Major Surgical Procedures, yes (%) | 283 (75.10) | 193 (70.90) | 476 (73.91) | 0.396†|
Parkinsonism, yes (%) | 0 (0.00) | 3 (1.10) | 3 (0.64) | < 0.001†|
Subjective cognitive decline, yes (%) | 236 (62.59) | 216 (79.41) | 452 (69.54) | < 0.001†|
Significant Visual Impairment, yes (%) | 23 (0.53) | 11 (4.12) | 33 (5.12) | 0.179†|
Significant Auditory Impairment, yes (%) | 33 (0.88) | 26 (9.74) | 59 (9.16) | 0.677†|
Clinical Scale | Â | Â | Â | Â |
Geriatric Depression Scale, mean [SD] | 1.34 [1.39] | 1.58 [1.39] | 1.44 [1.39] | 0.030‡ |
Hachinski ischemic Scores, mean [SD] | 0.60 [0.65] | 0.63 [0.78] | 0.61 [0.71] | 0.675‡ |